Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Go back to Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years| (NASDAQ: BNTX) | Delayed: 99.49 -4.27 (4.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.76 | 52 Week High | $ | |||
| Open | $100.24 | 52 Week Low | $ | |||
| Day High | $101.33 | P/E | N/A | |||
| Day Low | $98.18 | EPS | $ | |||
| Volume | 592,326 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.00 -0.45 (1.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.02 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.97 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 14,635,657 | |||||
